Bridged bicyclic aryl or heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases or conditions associated with Axl activity are also disclosed.
本文披露了桥联的双环芳基或杂环芳基取代的三唑化合物以及含有这些化合物的制药组合物可用于抑制受体
蛋白酪氨酸激酶Axl的活性。本文还披露了使用这些化合物治疗与Axl活性相关的疾病或症状的方法。